SAN DIEGO, Sept. 5 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, 2008 at approximately 2:45 p.m. Eastern Time. The presentation is scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website at http://www.gen-probe.com. The webcast will be available for 30 days following the event.
Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations, beliefs,
plans, objectives, assumptions or future events or performance are not
historical facts and are forward-looking statements. Forward-looking
statements are not guarantees of performance. They involve known and
unknown risks, uncertainties and assumptions that may cause actual results,
levels of activity, performance or achievements to differ materially from
those expressed or implied by any forward-looking statement. For
|SOURCE Gen-Probe Incorporated|
Copyright©2008 PR Newswire.
All rights reserved